Skip to content

Clinical trials

Phase 3 Squamous Cell Carcinoma of Head and Neck trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 3 Country / region: Belgium Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20101
20151
20161
20172
20203
20211
20244
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting5
Terminated4
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC4
AstraZeneca3
GlaxoSmithKline2
Merus B.V.2
AVEO Pharmaceuticals, Inc.1
Corbus Pharmaceuticals Inc.1
EMD Serono Research & Development Institute, Inc.1
Janssen Research & Development, LLC1
Johnson & Johnson Enterprise Innovation Inc.1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck20
Head and Neck Neoplasms10
Carcinoma, Squamous Cell3
Laryngeal Diseases2
Neoplasm Metastasis2
Recurrence2
Carcinoma1
Oropharyngeal Neoplasms1
Stomatitis1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.